|
1 / 1
|
DeCS
|
|
 |
|
Descriptor English:
|
|
Immunotherapy, Adoptive
|
|
Descriptor Spanish:
|
|
Inmunoterapia Adoptiva
|
|
Descriptor Portuguese:
|
|
Imunoterapia Adotiva
|
|
Synonyms English:
|
|
Adoptive Cellular Immunotherapies
Adoptive Cellular Immunotherapy
Adoptive Immunotherapies
Adoptive Immunotherapy
CAR T Cell Therapy
CAR T-Cell Therapies
CAR T-Cell Therapy
Cellular Immunotherapies, Adoptive
Cellular Immunotherapy, Adoptive
Chimeric Antigen Receptor Therapy
Immunotherapies, Adoptive
Immunotherapies, Adoptive Cellular
Immunotherapy, Adoptive Cellular
T-Cell Therapies, CAR
T-Cell Therapy, CAR
Therapies, CAR T-Cell
Therapy, CAR T-Cell
|
|
Tree Number:
|
|
E02.095.465.425.400.330.050.400
E05.478.550.520.050.400
|
|
Definition English:
|
|
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) |
|
Indexing Annotation English:
|
|
for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN
|
|
See Related English:
|
|
Receptors, Chimeric Antigen
|
|
History Note English:
|
|
1991
|
|
Allowable Qualifiers English:
|
|
|
|
Record Number:
|
|
28992
|
|
Unique Identifier:
|
|
D016219
|
Occurrence in VHL:
|
|
|
Similar:
|
|
DeCS
|
|